Publication | Open Access

Identification of curcumin derivatives as human LMTK3 inhibitors for breast cancer: a docking, dynamics, and MM/PBSA approach

Medicinal ChemistryMm/pbsa ApproachBreast OncologyChemoprevention StrategyMedicineBreast CancerTumor TargetingCurcumin DerivativesAnti-cancer AgentCancer TreatmentPharmacologyRadiation OncologyCancer ResearchTumor BiologyDrug Discovery